Scientific Symposium | Gene-Targeting Therapies in Epilepsy

Monday, December 7, 2026 at 9:00 AM to 11:30 AM · 2 hr. 30 min. (America/Denver)
Symposium

Information

The Scientific Symposium will focus on gene-targeting therapeutic approaches for the epilepsies. Advances in technology have led to an increasing number of ways to target specific genes, proteins, or pathways to treat the underlying cause in monogenic conditions. In the epilepsies, there are a number of approaches in clinical trials or under investigation for specific genetic disorders. The speakers will highlight promising classes of gene-targeting therapies, required pre-clinical studies and challenges on the path to clinical implementation, and clinical trial readiness in rare disease populations. Specific examples of therapy development and clinical trials in epilepsy will be discussed.
Learning Objective 1
Describe at least three different types of gene-targeting therapies being explored in monogenic epilepsies
Learning Objective 2
Demonstrate understanding of potential disease-specific outcome measures for clinical trials
Learning Objective 3
Identify challenges in implementation of novel therapies in a rare disease population
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)AdvocatesBehavioral Health ProvidersCommunity Health WorkersNursesPharmacistsScientists/ResearchersSocial WorkersTechnicians
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalFirst-time AttendeesYoung ProfessionalsResearch
Session Content Includes
and Inclusion (DEI)DiversityEquityPediatric
Education Credits
2.5 CME2.5 CNE2.5 CPE
Session ID
SCISYMP26
Presentation Id
3451823
Event ID
24056
Session Type
Session